The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwMyeloma 2023 | The future of myeloma therapy
In this session, Keith Stewart, MBChB, MRCP, FRCPC, MBA, Princess Margaret Cancer Centre, Toronto, Canada, Brian Walker, PhD, Indiana University School of Medicine, Indianapolis, IN, Martin Kortüm, MD, University Hospital Würzburg, Würzburg, Germany, and Claudia Stege, MD, PhD, Amsterdam UMC, Amsterdam, Netherlands, have a fascinating discussion about the future of myeloma therapy, covering topics including challenges in performing translational studies, imaging modalities to prevent disease progression, incorporating frailty in clinical trial designs, and individualizing therapy. This session was filmed at the 16th International Workshop on Multiple Myeloma (iwMyeloma) held in Madrid, Spain.
